The Longevity Science Advisory Panel is dedicated to exploring the impact that a range of factors may have on future life expectancy in the UK. This includes the drivers that are enhancing life expectancy for example, medical advances and social change, as well as the inhibitors such as aspects of lifestyle and delays in development of treatments.
The Longevity Science Advisory Panel will regularly be presented with issues and papers on scientific developments for them to review and analyse to determine the implications on future UK life expectancy. The opinion of the panel will then be shared across the insurance industry, as well as with government, and public offices, where appropriate. The aim is that the panel will be a key source for learning and understanding on the implications of scientific developments on UK life expectancy.
‘We are delighted to announce the appointment of Dame Karen Dunnell as chair of the Longevity Science Advisory Panel in succession to Sir Derek Wanless who died in 2012. Dame Karen's leadership in data sources and expertise in socio-economic implications of demographic trends complement the Panel members' multi-disciplinary background. Her experience in scientific collaborations and public policy will provide invaluable insights as the Panel works toward a better understanding of human longevity trends and their implications for society.’Sir John Pattison on behalf of the Longevity Science Advisory Panel
‘I am honoured to follow in the footsteps of Derek Wanless. I first met Derek when he was carrying out research for his reports for the Treasury on health and health care. His interest in statistics and other evidence was fundamental to this work. I got to know him better when he became a founder member of the Statistics Commission, an independent body set up to help build trust in government statistics. At the time I was a senior member of ONS and then began to see even more of him when I became the National Statistician in 2005.’Dame Karen Dunnell